RankAlpha logo
Back to Rankings

OTLK

Outlook TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
OTLK vs peer average
40/100
OTLK vs. peer average (F vs. D)
Grade spread
A 1 · D 1 · F 6
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

HUMA is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $130.59M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerHUMAHumacyte
OTLK
Outlook Therapeutics
HUMA
Humacyte
Grade
F
F
Momentum
21
13
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare top peers (up to 3)

Grade position vs HUMA

OTLK / HUMA
Grade Position
Below peers
OTLK vs. peer average (F vs. D)
40/100
Momentum
21
OTLK
Value
41
OTLK
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OTLK
1
HUMA
Humacyte Inc Common
F
20/100
Even
2
OGI
Organigram Global Inc Common
F
20/100
Even
3
SPRB
Spruce Biosciences Inc Common
D
40/100
+1
4
BGM
BGM Group Ltd Class A Common
F
20/100
Even
5
BNR
Burning Rock Biotech Ltd ADR
F
20/100
Even
HUMA is the first peer returned for this comparison set.